https://www.rubedolife.com/media-press-release/turning-back-the-aging-clock-in-mice/ 2022-06-12T20:37:37+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/purging-the-body-of-retired-cells-could-reverse-ageing-study-shows/ 2022-06-12T20:38:26+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/the-anti-ageing-compound-scientists-create-a-chemical-that-can-restore-hair-and-give-youthful-energy/ 2018-11-13T16:38:35+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/drug-reverses-ageing-in-animal-tests/ 2018-11-13T16:40:00+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/targeting-chronic-diseases-through-geroscience/ 2019-10-22T22:24:52+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/ending-age-related-disease-conference-2020/ 2020-07-22T22:15:13+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/another-new-senolytic-prodrug-is-demonstrated-to-reverse-frailty-and-loss-of-cognitive-function-in-old-mice/ 2020-10-28T02:00:00+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/sens-internship-at-rubedo/ 2022-06-14T07:39:09+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/longevity-therapeutics-2021/ 2022-06-12T20:39:52+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-listed-among-top-senolytic-companies-in-recent-review-on-nature-biotechnology/ 2022-06-12T20:40:32+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-closes-12m-seed-financing-led-by-khosla-ventures/ 2022-06-12T20:40:56+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/news-briefing-new-senescent-cell-play-launches-with-12m/ 2022-06-12T20:41:24+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/venture-capitalists-back-biotech-push-to-combat-aging/ 2022-06-13T17:23:35+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/longevity-leaders/ 2022-06-12T20:43:31+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-collaborates-with-cedars-sinai-on-senolytic-ipf-program/ 2022-08-31T22:07:43+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-wins-the-biotechnology-award-2022/ 2022-06-24T16:32:11+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-announces-expansion-of-scientific-advisory-board/ 2022-06-24T16:30:39+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/aging-research-drug-discovery-meeting-2022/ 2022-08-31T22:06:46+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-receives-1-45m-award-from-california-institute-for-regenerative-medicine-cirm-to-advance-its-pulmonary-fibrosis-program/ 2023-02-10T10:28:14+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-presents-in-vivo-efficacy-data-targeting-senescence-cells-to-treat-dermatological-diseases/ 2023-03-20T19:19:57+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-ceo-dr-quarta-to-present-at-lsx-world-conference-london/ 2023-05-04T17:35:41+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-announces-nomination-of-first-in-class-disease-modifying-candidate-rls-1496-in-dermatology-at-lsx-world-congress-2023/ 2023-05-04T17:28:16+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-closes-40m-series-a-financing-led-by-khosla-ventures-and-ahren-innovation-capital/ 2024-04-22T17:44:37+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-pulls-in-40m-series-a-to-advance-atopic-dermatitis-candidate-targeting-aging-cells/ 2024-04-22T17:44:22+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/with-40-million-rubedo-life-sciences-aims-to-clear-away-aging-cells/ 2024-04-22T17:45:19+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-and-beiersdorf-announce-multi-year-partnership-to-pioneer-new-skin-care-products-that-address-cellular-aging/ 2024-04-23T16:54:36+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-announces-european-expansion-ahead-of-first-clinical-trial/ 2024-10-23T21:03:21+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-appoints-former-allergan-executive-and-biotechnology-veteran-dr-frederick-beddingfield-iii-as-ceo/ 2024-12-18T11:46:04+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-announces-clinical-development-plans-for-lead-candidate-rls-1496-a-first-in-class-gpx4-modulator-targeting-aging-cells-and-surrounding-tissues/ 2025-01-21T09:30:07+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-drug-discovery-platform-alembic-helps-identify-senescent-or-zombie-neurons-in-new-study-linking-neuropathic-pain-and-aging-published-in-peer/ 2025-05-15T16:56:21+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-announces-first-patient-dosed-with-lead-drug-candidate-rls-1496-the-first-gpx4-modulator-targeting-pathologic-senescent-cells-to-enter-phase-1-clinical-trial/ 2025-05-22T16:15:39+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-and-svax-announce-strategic-partnership-during-fii-week-in-riyadh/ 2025-10-30T22:06:41+00:00 monthly 0.6 https://www.rubedolife.com/media-press-release/rubedo-life-sciences-announces-u-s-fda-clearance-of-ind-for-selective-gpx4-modulating-lead-drug-candidate-rls-1496-for-actinic-keratosis-expands-clinical-advisory-board/ 2025-10-30T20:35:15+00:00 monthly 0.6